Connect Biopharma Holdings Limited
CNTB
$2.45
-$0.23-8.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -52.68% | -- | -34.90% | -29.00% | -20.79% |
| Total Receivables | -84.68% | -- | -94.58% | -- | 199.43% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 191.83% | -- | 165.60% | -- | -42.73% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -47.47% | -- | -32.91% | -- | -20.88% |
|
|
|||||
| Total Current Assets | -47.47% | -- | -32.91% | -- | -20.88% |
| Net Property, Plant & Equipment | 5.15% | -- | 7.90% | -- | -10.54% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -15.09% | -- | -15.79% | -- | -14.52% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1,857.58% | -- | -53.13% | -- | 37.50% |
| Total Assets | -44.64% | -- | -31.39% | -- | -20.48% |
|
|
|||||
| Total Accounts Payable | 474.27% | -- | -59.76% | -- | -84.52% |
| Total Accrued Expenses | 43.04% | -- | 151.20% | -- | -17.69% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 109.09% | -- | 38.89% | -- | -45.96% |
| Total Finance Division Other Current Liabilities | 1.83% | -- | -68.03% | -- | -98.77% |
| Total Other Current Liabilities | 1.83% | -- | -68.03% | -- | -98.77% |
| Total Current Liabilities | 60.87% | -- | 11.61% | -- | -66.54% |
|
|
|||||
| Total Current Liabilities | 60.87% | -- | 11.61% | -- | -66.54% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1,433.33% | -- | 612.33% | -- | -86.67% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -81.96% | -- | -69.04% | -- | 56.05% |
| Total Liabilities | 54.58% | -- | 12.80% | -- | -64.77% |
|
|
|||||
| Common Stock & APIC | 1.10% | -- | -29.81% | -- | 1.61% |
| Retained Earnings | -16.06% | -- | 30.69% | -- | -4.74% |
| Treasury Stock & Other | 25.73% | -- | -111.70% | -- | -55.39% |
| Total Common Equity | -54.45% | -- | -35.42% | -18.32% | -9.19% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -54.45% | -- | -35.42% | -18.32% | -9.19% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -54.45% | -- | -35.42% | -18.32% | -9.19% |
|
|
|||||